Description
For diagnosis of acute leukemia
Acute leukemia panel – Comprehensive -CD3,CD4,CD5,CD7,CD8,CD10,CD19,CD22,CD13,CD14,CD15,CD33,CD117,CD34,CD41,CD61,GLYCOPHORIN A, HLADR, cCD3, cCD22, cCD79a, cMPO, TdT
For diagnosis of acute leukemia
TAT: 1 day
Specimen Type: Blood / Bone marrow aspirate
Flowcytometry Panel Test
Other Tests
-
259%
HLA B27 by PCR
NIL
-
232%
CD3/CD16/CD56 (Natural Killer Cells) (NKC)
Useful in patients of Bad Obstetric history and recurrent abortions
CD3/CD16/CD56 (Natural Killer Cells) (NKC)
Useful in patients of Bad Obstetric history and recurrent abortions
-
231%
CD 34
CD34+ cell quantification is necessary to determine the optimal timing and to confirm the adequacy of Peripheral Blood Stem Cell (PBSC) harvests. This assay also helps to determine when to perform Bone marrow stem cell transplants; whether to continue Apheresis and to assess bone marrow and Cord blood viability. CD34+ absolute count is a critical parameter for rapid and sustained engraftment.
CD 34
CD34+ cell quantification is necessary to determine the optimal timing and to confirm the adequacy of Peripheral Blood Stem Cell (PBSC) harvests. This assay also helps to determine when to perform Bone marrow stem cell transplants; whether to continue Apheresis and to assess bone marrow and Cord blood viability. CD34+ absolute count is a critical parameter for rapid and sustained engraftment.
-
233%
CD34 Count
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.
CD34 Count
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.
Reviews
There are no reviews yet.